Global Human Coagulation Factor VIII Market Insights and Forecast to 2028

Report ID: 1152950 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Coagulation Factor Ⅷ Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Recombinant Factor VIII
        1.2.3 Human Factor VIII
    1.3 Market by Application
        1.3.1 Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hemophilia A
        1.3.3 Relvent Bleeding Diseases
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Human Coagulation Factor Ⅷ Sales Estimates and Forecasts 2017-2028
    2.2 Global Human Coagulation Factor Ⅷ Revenue Estimates and Forecasts 2017-2028
    2.3 Global Human Coagulation Factor Ⅷ Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Human Coagulation Factor Ⅷ Sales by Region
        2.4.1 Global Human Coagulation Factor Ⅷ Sales by Region (2017-2022)
        2.4.2 Global Sales Human Coagulation Factor Ⅷ by Region (2023-2028)
    2.5 Global Human Coagulation Factor Ⅷ Revenue by Region
        2.5.1 Global Human Coagulation Factor Ⅷ Revenue by Region (2017-2022)
        2.5.2 Global Human Coagulation Factor Ⅷ Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Coagulation Factor Ⅷ Sales by Manufacturers
        3.1.1 Global Top Human Coagulation Factor Ⅷ Manufacturers by Sales (2017-2022)
        3.1.2 Global Human Coagulation Factor Ⅷ Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Coagulation Factor Ⅷ in 2021
    3.2 Global Human Coagulation Factor Ⅷ Revenue by Manufacturers
        3.2.1 Global Human Coagulation Factor Ⅷ Revenue by Manufacturers (2017-2022)
        3.2.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor Ⅷ Revenue in 2021
    3.3 Global Human Coagulation Factor Ⅷ Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Coagulation Factor Ⅷ Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Human Coagulation Factor Ⅷ Sales by Type
        4.1.1 Global Human Coagulation Factor Ⅷ Historical Sales by Type (2017-2022)
        4.1.2 Global Human Coagulation Factor Ⅷ Forecasted Sales by Type (2023-2028)
        4.1.3 Global Human Coagulation Factor Ⅷ Sales Market Share by Type (2017-2028)
    4.2 Global Human Coagulation Factor Ⅷ Revenue by Type
        4.2.1 Global Human Coagulation Factor Ⅷ Historical Revenue by Type (2017-2022)
        4.2.2 Global Human Coagulation Factor Ⅷ Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2017-2028)
    4.3 Global Human Coagulation Factor Ⅷ Price by Type
        4.3.1 Global Human Coagulation Factor Ⅷ Price by Type (2017-2022)
        4.3.2 Global Human Coagulation Factor Ⅷ Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Human Coagulation Factor Ⅷ Sales by Application
        5.1.1 Global Human Coagulation Factor Ⅷ Historical Sales by Application (2017-2022)
        5.1.2 Global Human Coagulation Factor Ⅷ Forecasted Sales by Application (2023-2028)
        5.1.3 Global Human Coagulation Factor Ⅷ Sales Market Share by Application (2017-2028)
    5.2 Global Human Coagulation Factor Ⅷ Revenue by Application
        5.2.1 Global Human Coagulation Factor Ⅷ Historical Revenue by Application (2017-2022)
        5.2.2 Global Human Coagulation Factor Ⅷ Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2017-2028)
    5.3 Global Human Coagulation Factor Ⅷ Price by Application
        5.3.1 Global Human Coagulation Factor Ⅷ Price by Application (2017-2022)
        5.3.2 Global Human Coagulation Factor Ⅷ Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Human Coagulation Factor Ⅷ Market Size by Type
        6.1.1 North America Human Coagulation Factor Ⅷ Sales by Type (2017-2028)
        6.1.2 North America Human Coagulation Factor Ⅷ Revenue by Type (2017-2028)
    6.2 North America Human Coagulation Factor Ⅷ Market Size by Application
        6.2.1 North America Human Coagulation Factor Ⅷ Sales by Application (2017-2028)
        6.2.2 North America Human Coagulation Factor Ⅷ Revenue by Application (2017-2028)
    6.3 North America Human Coagulation Factor Ⅷ Market Size by Country
        6.3.1 North America Human Coagulation Factor Ⅷ Sales by Country (2017-2028)
        6.3.2 North America Human Coagulation Factor Ⅷ Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Human Coagulation Factor Ⅷ Market Size by Type
        7.1.1 Europe Human Coagulation Factor Ⅷ Sales by Type (2017-2028)
        7.1.2 Europe Human Coagulation Factor Ⅷ Revenue by Type (2017-2028)
    7.2 Europe Human Coagulation Factor Ⅷ Market Size by Application
        7.2.1 Europe Human Coagulation Factor Ⅷ Sales by Application (2017-2028)
        7.2.2 Europe Human Coagulation Factor Ⅷ Revenue by Application (2017-2028)
    7.3 Europe Human Coagulation Factor Ⅷ Market Size by Country
        7.3.1 Europe Human Coagulation Factor Ⅷ Sales by Country (2017-2028)
        7.3.2 Europe Human Coagulation Factor Ⅷ Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Coagulation Factor Ⅷ Market Size by Type
        8.1.1 Asia Pacific Human Coagulation Factor Ⅷ Sales by Type (2017-2028)
        8.1.2 Asia Pacific Human Coagulation Factor Ⅷ Revenue by Type (2017-2028)
    8.2 Asia Pacific Human Coagulation Factor Ⅷ Market Size by Application
        8.2.1 Asia Pacific Human Coagulation Factor Ⅷ Sales by Application (2017-2028)
        8.2.2 Asia Pacific Human Coagulation Factor Ⅷ Revenue by Application (2017-2028)
    8.3 Asia Pacific Human Coagulation Factor Ⅷ Market Size by Region
        8.3.1 Asia Pacific Human Coagulation Factor Ⅷ Sales by Region (2017-2028)
        8.3.2 Asia Pacific Human Coagulation Factor Ⅷ Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Human Coagulation Factor Ⅷ Market Size by Type
        9.1.1 Latin America Human Coagulation Factor Ⅷ Sales by Type (2017-2028)
        9.1.2 Latin America Human Coagulation Factor Ⅷ Revenue by Type (2017-2028)
    9.2 Latin America Human Coagulation Factor Ⅷ Market Size by Application
        9.2.1 Latin America Human Coagulation Factor Ⅷ Sales by Application (2017-2028)
        9.2.2 Latin America Human Coagulation Factor Ⅷ Revenue by Application (2017-2028)
    9.3 Latin America Human Coagulation Factor Ⅷ Market Size by Country
        9.3.1 Latin America Human Coagulation Factor Ⅷ Sales by Country (2017-2028)
        9.3.2 Latin America Human Coagulation Factor Ⅷ Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Human Coagulation Factor Ⅷ Market Size by Type
        10.1.1 Middle East and Africa Human Coagulation Factor Ⅷ Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Human Coagulation Factor Ⅷ Revenue by Type (2017-2028)
    10.2 Middle East and Africa Human Coagulation Factor Ⅷ Market Size by Application
        10.2.1 Middle East and Africa Human Coagulation Factor Ⅷ Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Human Coagulation Factor Ⅷ Revenue by Application (2017-2028)
    10.3 Middle East and Africa Human Coagulation Factor Ⅷ Market Size by Country
        10.3.1 Middle East and Africa Human Coagulation Factor Ⅷ Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Human Coagulation Factor Ⅷ Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bayer
        11.1.1 Bayer Corporation Information
        11.1.2 Bayer Overview
        11.1.3 Bayer Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bayer Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bayer Recent Developments
    11.2 CSL Behring
        11.2.1 CSL Behring Corporation Information
        11.2.2 CSL Behring Overview
        11.2.3 CSL Behring Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 CSL Behring Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 CSL Behring Recent Developments
    11.3 Baxter
        11.3.1 Baxter Corporation Information
        11.3.2 Baxter Overview
        11.3.3 Baxter Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Baxter Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Baxter Recent Developments
    11.4 Grifols
        11.4.1 Grifols Corporation Information
        11.4.2 Grifols Overview
        11.4.3 Grifols Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Grifols Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Grifols Recent Developments
    11.5 Octapharma
        11.5.1 Octapharma Corporation Information
        11.5.2 Octapharma Overview
        11.5.3 Octapharma Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Octapharma Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Octapharma Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Corporation Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Pfizer Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 Taibang Bio
        11.7.1 Taibang Bio Corporation Information
        11.7.2 Taibang Bio Overview
        11.7.3 Taibang Bio Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Taibang Bio Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Taibang Bio Recent Developments
    11.8 Shanghai Laishi
        11.8.1 Shanghai Laishi Corporation Information
        11.8.2 Shanghai Laishi Overview
        11.8.3 Shanghai Laishi Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Shanghai Laishi Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Shanghai Laishi Recent Developments
    11.9 Hualan Bio
        11.9.1 Hualan Bio Corporation Information
        11.9.2 Hualan Bio Overview
        11.9.3 Hualan Bio Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Hualan Bio Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Hualan Bio Recent Developments
    11.10 Guangdong Shuanglin
        11.10.1 Guangdong Shuanglin Corporation Information
        11.10.2 Guangdong Shuanglin Overview
        11.10.3 Guangdong Shuanglin Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Guangdong Shuanglin Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Guangdong Shuanglin Recent Developments
    11.11 GreenCross
        11.11.1 GreenCross Corporation Information
        11.11.2 GreenCross Overview
        11.11.3 GreenCross Human Coagulation Factor Ⅷ Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 GreenCross Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 GreenCross Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Human Coagulation Factor Ⅷ Industry Chain Analysis
    12.2 Human Coagulation Factor Ⅷ Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Coagulation Factor Ⅷ Production Mode & Process
    12.4 Human Coagulation Factor Ⅷ Sales and Marketing
        12.4.1 Human Coagulation Factor Ⅷ Sales Channels
        12.4.2 Human Coagulation Factor Ⅷ Distributors
    12.5 Human Coagulation Factor Ⅷ Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Coagulation Factor Ⅷ Industry Trends
    13.2 Human Coagulation Factor Ⅷ Market Drivers
    13.3 Human Coagulation Factor Ⅷ Market Challenges
    13.4 Human Coagulation Factor Ⅷ Market Restraints
14 Key Findings in The Global Human Coagulation Factor Ⅷ Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Recombinant Factor VIII
    Table 3. Major Manufacturers of Human Factor VIII
    Table 4. Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Human Coagulation Factor Ⅷ Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Human Coagulation Factor Ⅷ Sales by Region (2017-2022) & (K Units)
    Table 7. Global Human Coagulation Factor Ⅷ Sales Market Share by Region (2017-2022)
    Table 8. Global Human Coagulation Factor Ⅷ Sales by Region (2023-2028) & (K Units)
    Table 9. Global Human Coagulation Factor Ⅷ Sales Market Share by Region (2023-2028)
    Table 10. Global Human Coagulation Factor Ⅷ Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Human Coagulation Factor Ⅷ Revenue Market Share by Region (2017-2022)
    Table 12. Global Human Coagulation Factor Ⅷ Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Human Coagulation Factor Ⅷ Revenue Market Share by Region (2023-2028)
    Table 14. Global Human Coagulation Factor Ⅷ Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Human Coagulation Factor Ⅷ Sales Share by Manufacturers (2017-2022)
    Table 16. Global Human Coagulation Factor Ⅷ Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Human Coagulation Factor Ⅷ Revenue Share by Manufacturers (2017-2022)
    Table 18. Human Coagulation Factor Ⅷ Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Human Coagulation Factor Ⅷ Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Human Coagulation Factor Ⅷ by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2021)
    Table 21. Human Coagulation Factor Ⅷ Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Human Coagulation Factor Ⅷ Product Offered
    Table 23. Date of Manufacturers Enter into Human Coagulation Factor Ⅷ Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Human Coagulation Factor Ⅷ Sales by Type (2017-2022) & (K Units)
    Table 26. Global Human Coagulation Factor Ⅷ Sales by Type (2023-2028) & (K Units)
    Table 27. Global Human Coagulation Factor Ⅷ Sales Share by Type (2017-2022)
    Table 28. Global Human Coagulation Factor Ⅷ Sales Share by Type (2023-2028)
    Table 29. Global Human Coagulation Factor Ⅷ Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Human Coagulation Factor Ⅷ Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Human Coagulation Factor Ⅷ Revenue Share by Type (2017-2022)
    Table 32. Global Human Coagulation Factor Ⅷ Revenue Share by Type (2023-2028)
    Table 33. Human Coagulation Factor Ⅷ Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Human Coagulation Factor Ⅷ Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Human Coagulation Factor Ⅷ Sales by Application (2017-2022) & (K Units)
    Table 36. Global Human Coagulation Factor Ⅷ Sales by Application (2023-2028) & (K Units)
    Table 37. Global Human Coagulation Factor Ⅷ Sales Share by Application (2017-2022)
    Table 38. Global Human Coagulation Factor Ⅷ Sales Share by Application (2023-2028)
    Table 39. Global Human Coagulation Factor Ⅷ Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Human Coagulation Factor Ⅷ Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Human Coagulation Factor Ⅷ Revenue Share by Application (2017-2022)
    Table 42. Global Human Coagulation Factor Ⅷ Revenue Share by Application (2023-2028)
    Table 43. Human Coagulation Factor Ⅷ Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Human Coagulation Factor Ⅷ Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Human Coagulation Factor Ⅷ Sales by Type (2017-2022) & (K Units)
    Table 46. North America Human Coagulation Factor Ⅷ Sales by Type (2023-2028) & (K Units)
    Table 47. North America Human Coagulation Factor Ⅷ Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Human Coagulation Factor Ⅷ Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Human Coagulation Factor Ⅷ Sales by Application (2017-2022) & (K Units)
    Table 50. North America Human Coagulation Factor Ⅷ Sales by Application (2023-2028) & (K Units)
    Table 51. North America Human Coagulation Factor Ⅷ Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Human Coagulation Factor Ⅷ Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Human Coagulation Factor Ⅷ Sales by Country (2017-2022) & (K Units)
    Table 54. North America Human Coagulation Factor Ⅷ Sales by Country (2023-2028) & (K Units)
    Table 55. North America Human Coagulation Factor Ⅷ Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Human Coagulation Factor Ⅷ Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Human Coagulation Factor Ⅷ Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Human Coagulation Factor Ⅷ Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Human Coagulation Factor Ⅷ Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Human Coagulation Factor Ⅷ Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Human Coagulation Factor Ⅷ Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Human Coagulation Factor Ⅷ Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Human Coagulation Factor Ⅷ Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Human Coagulation Factor Ⅷ Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Human Coagulation Factor Ⅷ Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Human Coagulation Factor Ⅷ Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Human Coagulation Factor Ⅷ Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Human Coagulation Factor Ⅷ Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Human Coagulation Factor Ⅷ Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Human Coagulation Factor Ⅷ Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Human Coagulation Factor Ⅷ Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Human Coagulation Factor Ⅷ Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Human Coagulation Factor Ⅷ Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Human Coagulation Factor Ⅷ Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Human Coagulation Factor Ⅷ Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Human Coagulation Factor Ⅷ Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Human Coagulation Factor Ⅷ Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Human Coagulation Factor Ⅷ Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Human Coagulation Factor Ⅷ Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Human Coagulation Factor Ⅷ Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Human Coagulation Factor Ⅷ Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Human Coagulation Factor Ⅷ Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Human Coagulation Factor Ⅷ Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Human Coagulation Factor Ⅷ Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Human Coagulation Factor Ⅷ Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Human Coagulation Factor Ⅷ Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Human Coagulation Factor Ⅷ Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Human Coagulation Factor Ⅷ Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Human Coagulation Factor Ⅷ Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Human Coagulation Factor Ⅷ Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Human Coagulation Factor Ⅷ Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Human Coagulation Factor Ⅷ Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Human Coagulation Factor Ⅷ Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Human Coagulation Factor Ⅷ Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Human Coagulation Factor Ⅷ Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Human Coagulation Factor Ⅷ Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Human Coagulation Factor Ⅷ Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Human Coagulation Factor Ⅷ Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Human Coagulation Factor Ⅷ Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Human Coagulation Factor Ⅷ Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Human Coagulation Factor Ⅷ Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Human Coagulation Factor Ⅷ Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Human Coagulation Factor Ⅷ Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Human Coagulation Factor Ⅷ Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Bayer Corporation Information
    Table 106. Bayer Description and Major Businesses
    Table 107. Bayer Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Bayer Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Bayer Recent Developments
    Table 110. CSL Behring Corporation Information
    Table 111. CSL Behring Description and Major Businesses
    Table 112. CSL Behring Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. CSL Behring Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. CSL Behring Recent Developments
    Table 115. Baxter Corporation Information
    Table 116. Baxter Description and Major Businesses
    Table 117. Baxter Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Baxter Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Baxter Recent Developments
    Table 120. Grifols Corporation Information
    Table 121. Grifols Description and Major Businesses
    Table 122. Grifols Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Grifols Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Grifols Recent Developments
    Table 125. Octapharma Corporation Information
    Table 126. Octapharma Description and Major Businesses
    Table 127. Octapharma Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Octapharma Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Octapharma Recent Developments
    Table 130. Pfizer Corporation Information
    Table 131. Pfizer Description and Major Businesses
    Table 132. Pfizer Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Pfizer Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Pfizer Recent Developments
    Table 135. Taibang Bio Corporation Information
    Table 136. Taibang Bio Description and Major Businesses
    Table 137. Taibang Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Taibang Bio Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Taibang Bio Recent Developments
    Table 140. Shanghai Laishi Corporation Information
    Table 141. Shanghai Laishi Description and Major Businesses
    Table 142. Shanghai Laishi Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Shanghai Laishi Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Shanghai Laishi Recent Developments
    Table 145. Hualan Bio Corporation Information
    Table 146. Hualan Bio Description and Major Businesses
    Table 147. Hualan Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Hualan Bio Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Hualan Bio Recent Developments
    Table 150. Guangdong Shuanglin Corporation Information
    Table 151. Guangdong Shuanglin Description and Major Businesses
    Table 152. Guangdong Shuanglin Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Guangdong Shuanglin Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Guangdong Shuanglin Recent Developments
    Table 155. GreenCross Corporation Information
    Table 156. GreenCross Description and Major Businesses
    Table 157. GreenCross Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. GreenCross Human Coagulation Factor Ⅷ Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. GreenCross Recent Developments
    Table 160. Key Raw Materials Lists
    Table 161. Raw Materials Key Suppliers Lists
    Table 162. Human Coagulation Factor Ⅷ Distributors List
    Table 163. Human Coagulation Factor Ⅷ Customers List
    Table 164. Human Coagulation Factor Ⅷ Market Trends
    Table 165. Human Coagulation Factor Ⅷ Market Drivers
    Table 166. Human Coagulation Factor Ⅷ Market Challenges
    Table 167. Human Coagulation Factor Ⅷ Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Coagulation Factor Ⅷ Product Picture
    Figure 3. Global Human Coagulation Factor Ⅷ Market Share by Type in 2021 & 2028
    Figure 3. Recombinant Factor VIII Product Picture
    Figure 4. Human Factor VIII Product Picture
    Figure 5. Global Human Coagulation Factor Ⅷ Market Share by Application in 2021 & 2028
    Figure 6. Hemophilia A
    Figure 7. Relvent Bleeding Diseases
    Figure 8. Human Coagulation Factor Ⅷ Report Years Considered
    Figure 9. Global Human Coagulation Factor Ⅷ Sales 2017-2028 (K Units)
    Figure 10. Global Human Coagulation Factor Ⅷ Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Human Coagulation Factor Ⅷ Revenue 2017-2028 (US$ Million)
    Figure 12. Global Human Coagulation Factor Ⅷ Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Human Coagulation Factor Ⅷ Sales Market Share by Region (2017-2022)
    Figure 14. Global Human Coagulation Factor Ⅷ Sales Market Share by Region (2023-2028)
    Figure 15. North America Human Coagulation Factor Ⅷ Sales YoY (2017-2028) & (K Units)
    Figure 16. North America Human Coagulation Factor Ⅷ Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Human Coagulation Factor Ⅷ Sales YoY (2017-2028) & (K Units)
    Figure 18. Europe Human Coagulation Factor Ⅷ Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Human Coagulation Factor Ⅷ Sales YoY (2017-2028) & (K Units)
    Figure 20. Asia-Pacific Human Coagulation Factor Ⅷ Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Human Coagulation Factor Ⅷ Sales YoY (2017-2028) & (K Units)
    Figure 22. Latin America Human Coagulation Factor Ⅷ Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Human Coagulation Factor Ⅷ Sales YoY (2017-2028) & (K Units)
    Figure 24. Middle East & Africa Human Coagulation Factor Ⅷ Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Human Coagulation Factor Ⅷ Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Human Coagulation Factor Ⅷ in the World: Market Share by Human Coagulation Factor Ⅷ Revenue in 2021
    Figure 27. Global Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Human Coagulation Factor Ⅷ Sales Market Share by Type (2017-2028)
    Figure 29. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2017-2028)
    Figure 30. Global Human Coagulation Factor Ⅷ Sales Market Share by Application (2017-2028)
    Figure 31. Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2017-2028)
    Figure 32. North America Human Coagulation Factor Ⅷ Sales Market Share by Type (2017-2028)
    Figure 33. North America Human Coagulation Factor Ⅷ Revenue Market Share by Type (2017-2028)
    Figure 34. North America Human Coagulation Factor Ⅷ Sales Market Share by Application (2017-2028)
    Figure 35. North America Human Coagulation Factor Ⅷ Revenue Market Share by Application (2017-2028)
    Figure 36. North America Human Coagulation Factor Ⅷ Sales Share by Country (2017-2028)
    Figure 37. North America Human Coagulation Factor Ⅷ Revenue Share by Country (2017-2028)
    Figure 38. U.S. Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Human Coagulation Factor Ⅷ Sales Market Share by Type (2017-2028)
    Figure 41. Europe Human Coagulation Factor Ⅷ Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Human Coagulation Factor Ⅷ Sales Market Share by Application (2017-2028)
    Figure 43. Europe Human Coagulation Factor Ⅷ Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Human Coagulation Factor Ⅷ Sales Share by Country (2017-2028)
    Figure 45. Europe Human Coagulation Factor Ⅷ Revenue Share by Country (2017-2028)
    Figure 46. Germany Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 47. France Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Human Coagulation Factor Ⅷ Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Human Coagulation Factor Ⅷ Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Human Coagulation Factor Ⅷ Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Human Coagulation Factor Ⅷ Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Human Coagulation Factor Ⅷ Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Human Coagulation Factor Ⅷ Revenue Share by Region (2017-2028)
    Figure 57. China Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 60. India Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Human Coagulation Factor Ⅷ Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Human Coagulation Factor Ⅷ Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Human Coagulation Factor Ⅷ Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Human Coagulation Factor Ⅷ Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Human Coagulation Factor Ⅷ Sales Share by Country (2017-2028)
    Figure 72. Latin America Human Coagulation Factor Ⅷ Revenue Share by Country (2017-2028)
    Figure 73. Mexico Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Human Coagulation Factor Ⅷ Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Human Coagulation Factor Ⅷ Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Human Coagulation Factor Ⅷ Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Human Coagulation Factor Ⅷ Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Human Coagulation Factor Ⅷ Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Human Coagulation Factor Ⅷ Revenue Share by Country (2017-2028)
    Figure 82. Turkey Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Human Coagulation Factor Ⅷ Revenue (2017-2028) & (US$ Million)
    Figure 85. Human Coagulation Factor Ⅷ Value Chain
    Figure 86. Human Coagulation Factor Ⅷ Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
CSL Behring
Baxter
Grifols
Octapharma
Pfizer
Taibang Bio
Shanghai Laishi
Hualan Bio
Guangdong Shuanglin
GreenCross
Frequently Asked Questions
Human Coagulation Factor VIII report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Coagulation Factor VIII report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Coagulation Factor VIII report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Wireless Antenna

Wireless Antenna market is segmented by Type and by Application. Players, stakeholders, and other ... Read More

Solvent Naphtha

Solvent Naphtha market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More